Episodic Migraine Clinical Trials

16 recruiting

Episodic Migraine Trials at a Glance

18 actively recruiting trials for episodic migraine are listed on ClinicalTrialsFinder across 6 cities in 37 countries. The largest study group is Phase 3 with 4 trials, with the heaviest enrollment activity in Wroclaw, Pavia, and Madrid. Lead sponsors running episodic migraine studies include IRCCS National Neurological Institute "C. Mondino" Foundation, AbbVie, and Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta.

Browse episodic migraine trials by phase

Treatments under study

About Episodic Migraine Clinical Trials

Looking for clinical trials for Episodic Migraine? There are currently 16 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Episodic Migraine trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Episodic Migraine clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 118 of 18 trials

Recruiting
Phase 3

A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine

Episodic Migraine
Merz Therapeutics GmbH990 enrolled106 locationsNCT07018700
Recruiting
Not Applicable

The RECLAIM Study.

Chronic MigraineHigh Frequency Episodic Migraine
Salvia BioElectronics110 enrolled11 locationsNCT06450444
Recruiting
Phase 3

Efficacy of Gou-Teng-San (GTS) in Patients With Episodic Migraine: A Double-Blind Randomized Controlled Trial

Episodic Migraine
Tsai, Chueh-Yi, MD40 enrolled1 locationNCT07496034
Recruiting
Phase 3

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine

Episodic Migraine
AbbVie450 enrolled98 locationsNCT05711394
Recruiting
Phase 3

A Study of Eptinezumab in Pediatric Participants With Episodic Migraine

Episodic Migraine
H. Lundbeck A/S315 enrolled65 locationsNCT05897320
Recruiting
Phase 2

Efficacy of Nerve Blocks for Episodic Migraine

Episodic Migraine
Mayo Clinic60 enrolled1 locationNCT05734625
Recruiting
Phase 2

A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults

Chronic MigraineEpisodic Migraine
Ipsen641 enrolled166 locationsNCT06625060
Recruiting
Phase 2

Prophylactic Treatment With Atorvastatin for Episodic Migraine.

Episodic Migraine
St. Olavs Hospital450 enrolled6 locationsNCT06248671
Recruiting

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine

MigraineChronic MigraineEpisodic Migraine
AbbVie3,000 enrolled4 locationsNCT06603558
Recruiting

Real-world Prospective Study on the Use of Anti-CGRP Drugs in Migraine

MigraineEpisodic MigraineChronic Migraine, Headache
Hospital Universitari Vall d'Hebron Research Institute700 enrolled26 locationsNCT07159750
Recruiting

i-NEED: NEw migrainE Drugs Database

Chronic MigraineEpisodic Migraine
IRCCS San Raffaele Roma2,641 enrolled1 locationNCT07103694
Recruiting
Not Applicable

Chiropractic Care for Episodic Migraine

Episodic Migraine
Brigham and Women's Hospital60 enrolled1 locationNCT06229834
Recruiting

High-Density EEG-MEG-wearable EEG: Comparison of Quantitative Electroencephalographic Indicators as Neurophysiological Markers of Effectiveness of Mindfulness Therapy in Addition to Standard Treatment in Patients With High-frequency Episodic Migraine

MigraineMigraine DiseaseHigh Frequency Episodic Migraine
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta40 enrolled1 locationNCT06938178
Recruiting

Neurophysiological and Biomolecular Effects of Atogepant in Episodic Migraine

Episodic MigraineMigraine Disorder
IRCCS National Neurological Institute "C. Mondino" Foundation30 enrolled1 locationNCT06882122
Recruiting

CGRP Inhibition, Autonomic Function, and Migraine

Chronic MigraineEpisodic Migraine
Medical University of Vienna120 enrolled1 locationNCT04628429
Recruiting

Biochemical Profiling of Migraine Patients

Chronic MigraineMigraine DisordersEpisodic Migraine
IRCCS National Neurological Institute "C. Mondino" Foundation100 enrolled1 locationNCT06549270
Recruiting

Searching for Novel Therapeutic Approaches in Migraine Patients Resistant to Treatments

Chronic MigraineMigraine DisordersEpisodic Migraine
IRCCS National Neurological Institute "C. Mondino" Foundation45 enrolled1 locationNCT06562400
Recruiting

Searching for Novel Biological Phenotypes in Migraine Patients Resistant to Treatments

Chronic MigraineMigraine DisordersEpisodic Migraine
IRCCS National Neurological Institute "C. Mondino" Foundation100 enrolled1 locationNCT06562413